2d
Zacks Investment Research on MSNAmedisys (AMED) Earnings Expected to Grow: Should You Buy?The market expects Amedisys (AMED) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...
who has an outperform rating on Amedisys wrote in a note on Monday. Investors are concerned about a potential lawsuit DOJ ...
Amedisys, Inc. (NASDAQ:AMED – Free Report) – Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for Amedisys in a note issued to investors on Wednesday, January 29th.
Stock analysts at Leerink Partnrs raised their FY2026 earnings per share estimates for shares of Amedisys in a research ...
Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agreed to combine. The agreement calls for the ...
BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results